Empowering Patients' Lung Cancer Screening Uptake

Last updated: March 23, 2025
Sponsor: University of California, Irvine
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Lung Cancer

Lung Disease

Non-small Cell Lung Cancer

Treatment

Provider Reminers

Patient Reminders

Referral to financial navigation resources

Clinical Study ID

NCT06000683
UCI 23-107
3439
  • Ages 50-80
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Lung cancer is the leading cause of cancer related mortality. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases mortality rate of lung cancer by 20%. Yet many patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients the ability to detect lung cancer early. This study will test the effect of a a multi-level intervention on ordering LDCT within 6 months after patient enrollment. Our proposed intervention includes (1) Primary care provider notifications of patients' LCS eligibility; (2) patients' education ; (3) patients' referral to financial navigation resources; and (4) patients' reminder to discuss LCS during PCP visit.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Aged 50- 80 years of age.

  2. Be able to Speak English, Spanish, or Vietnamese

  3. Must have a scheduled appointment with their Primary Care Providers within next oneto three months.

  4. The Scheduled PCP appointment is at any of the UCI Health primary care clinics inOrange County including two UCI federally qualified health centers

  5. History of 20 pack year smoking history ( based on survey self report)

  6. Current smoker or a former smoker who has quit smoking within the last 15 years (based on survey self report)

Exclusion

Exclusion Criteria:

  1. Prior history of lung cancer

  2. chest CT for any reason in the last 12 months based on self-report and UCI EMR

  3. history of Alzheimer's disease or dementia

Study Design

Total Participants: 70
Treatment Group(s): 4
Primary Treatment: Provider Reminers
Phase:
Study Start date:
October 13, 2023
Estimated Completion Date:
December 31, 2025

Connect with a study center

  • UCI Health - Costa Mesa

    Costa Mesa, California 92627
    United States

    Site Not Available

  • UCI Health Gottschalk Medical Plaza

    Irvine, California 92697
    United States

    Site Not Available

  • UCI Health - Laguna Hills

    Laguna Hills, California 92653
    United States

    Site Not Available

  • UCI Health - Newport Beach MacArthur

    Newport Beach, California 92660
    United States

    Site Not Available

  • UCI Medical Center

    Orange, California 92868
    United States

    Site Not Available

  • UCI Health - Tustin

    Tustin, California 92670
    United States

    Site Not Available

  • UCI Health-Yorba Linda

    Yorba Linda, California 92886
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.